ESG

New research shows government digital services are widely available but rarely used, as legacy systems and low adoption create an invisible barrier to efficiency.

A new AI test promises to tell patients their personal benefit from chemotherapy, aiming to end decades of one-size-fits-all treatment decisions.

Soaring diesel prices are pushing Canada's truckers to the brink, threatening a fragile recovery and signaling higher costs for consumers on everything.

New research shows parents welcome corporate sponsors in schools to fill funding gaps, creating a powerful new marketing channel built on community trust.

Shanghai names Sanyou Bio a top municipal tech center, validating its AI-powered antibody library that's reshaping global drug R&D and fueling regional innovation.

The biotech firm's oversubscribed funding round will accelerate its universal flu shot and a diverse pipeline targeting cancer, malaria, and Alzheimer's.

In a strategic move to dominate the AI infrastructure boom, AVAIO Digital has hired industry pioneer Jason Norado to execute its multi-gigawatt expansion.

Danish firm Evaxion, backed by the Gates Foundation, uses its AI platform to design a next-gen polio vaccine, aiming to end the disease for good.

A new survey reveals a chasm between patriotic slogans and spending, as Canadian small businesses battle rising costs, cash flow crunches, and fading hope.

Roche has received FDA clearance for two new high-speed diagnostic units designed to alleviate lab staff shortages and dramatically increase testing capacity.

Phase 2 data for HRS/BHB-1893 show rapid efficacy and a simplified regimen, signaling a potential new era for treating hypertrophic cardiomyopathy.

Beyond apparel, Anthropologie and FARM Rio's new home line is a strategic play on maximalism, sustainability, and the power of a decade-long partnership.

A new pocket-sized, AI-powered ultrasound aims to revolutionize prenatal care in Africa, putting life-saving diagnostics into the hands of local caregivers.

German CDMO Vetter wins a prestigious, client-voted award, underscoring its pivotal role and massive €2 billion investment in the world of injectable biologics.

An amended deal with Tasly positions AP Biosciences to license its innovative bispecific cancer therapy to global pharma giants, targeting a lucrative market.

A new partnership aims to merge digital brain therapies with functional foods, targeting Japan and Southeast Asia's rapidly growing elderly populations.

Aurinia Pharmaceuticals' deal for Kezar Life Sciences hinges on zetomipzomib, a promising but risky drug poised to tackle a rare autoimmune liver disease.

Chef Gabriela Cámara and architect Frida Escobedo debut a sanctuary of Mexican hospitality, offering a quiet, authentic counterpoint to the Vegas spectacle.

DERMAFLASH launches its first sonic dermaplaning system for pros, promising a safer, more effective alternative to traditional scalpel-based treatments.

With a $700M war chest and a new veteran president, MISSION Underwriters aims to disrupt Latin America's facultative reinsurance market with its tech platform.